AB

ABBV

AbbVie Inc.

NYSE
Market Cap
P/E Ratio
11.48
Dividend Yield
3.48%
Volume
52W High
52W Low
Avg Volume
52W Range

Financial Statements

What does this mean?

Income statement, balance sheet, and cash flow over time

Metric
No financial data available

Institutional Ownership

What does this mean?

Top institutions holding ABBV

Institution Shares Held Value Date
Vanguard Group 150,000,000 $25,000,000,000 Oct 2025
BlackRock 140,000,000 $23,500,000,000 Nov 2025
State Street 80,000,000 $13,500,000,000 Nov 2025
Fidelity 65,000,000 $11,000,000,000 Nov 2025
Geode Capital 35,000,000 $5,900,000,000 Nov 2025

Top ETFs holding ABBV

ETF Weight Shares
QQQ 8.50% 23,197,022
VGT 6.20% 39,642,499
SPY 4.50% 37,996,544
IVV 4.20% 14,982,160
VOO 3.80% 7,413,766

Frequently Asked Questions

Common questions about ABBV

AbbVie Inc. (ABBV) is a publicly traded company listed on NYSE. AbbVie Inc. (ABBV) is included in the Stock Monitor database for research and watchlists. It operates in the Drug Manufacturers industry within the Healthcare sector.

The current stock price of ABBV is $208.48, with a change of +3.48% in the latest session. Stock prices are updated during market hours and may be delayed.

Yes, ABBV pays dividends with a current dividend yield of 3.48%. Dividend payments are typically made quarterly, though the exact schedule varies. Check the dividend calendar for upcoming ex-dividend dates.

The P/E (Price-to-Earnings) ratio of ABBV is 11.48. This relatively low P/E may indicate value potential or market concerns. The P/E ratio compares the stock price to earnings per share and is commonly used for valuation.

ABBV has a market capitalization of $1.55 trillion, making it a mega-cap company. Market cap is calculated by multiplying the current stock price by the total number of outstanding shares.

The 52-week trading range for ABBV is $166.37 (low) to $301.88 (high). This range represents the lowest and highest prices the stock has traded at over the past year.

ABBV belongs to the Healthcare sector specifically in the Drug Manufacturers industry. Understanding a company's sector helps investors compare it to peers and understand industry-specific trends that may affect performance.

Trade

Buy/Sell via broker links (affiliate).

Trading 212
Open Broker
Links may be affiliate links. Trading involves risk.

Paper Trade

Save a buy/sell to your portfolio tracker (not a real trade).

Sign in to save trades to your portfolio tracker.

Paper Orders

Limit/stop reminders, with optional bracket (take profit + stop loss).

Sign in to place paper orders.

Price Alerts

Notify when ABBV crosses your target.

Sign in to create alerts and sync them across devices.

About

AbbVie Inc. (ABBV) is included in the Stock Monitor database for research and watchlists.

CEO
N/A
Industry
Drug Manufacturers
Sector
Healthcare
Employees
171,348
IPO Date
Jan 1, 2000

Analyst Ratings

What does this mean?
Goldman Sachs
Nov 29, 2025
Buy
Morgan Stanley
Nov 12, 2025
Buy
JPMorgan
Oct 26, 2025
Hold
Bernstein
Oct 9, 2025
Hold
Piper Sandler
Sep 22, 2025
Overweight
Price Target
$225.16